Currently, the growth of the market studied is attributed to the increasing awareness about the potential benefits of targeted alpha therapy. In the efforts of making healthcare system better, the government, along with some companies, is spreading awareness about the treatment options for cancer, such as radiotherapy. The market studied is also growing due to the increasing incidences of cardiac and cancer ailments. The rise in prevalence of cardiac and cancer ailments is increasing the demand for alpha emitters. In addition to that, the ongoing research for the treatment of various cancer types is contributing to the market growth. Presently, there are certain factors that are hindering the growth of the market studied, and those factors include shorter half-life of radiopharmaceuticals, stringent regulatory framework, and the need for high capital investment.

1. INTRODUCTION  

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY 

4. MARKET DYNAMICS 

5. MARKET SEGMENTATION 

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE 

7. MARKET OPPORTUNITIES AND FUTURE TRENDS